Shares of Humacyte, Inc. (NASDAQ:HUMAW – Get Free Report) shot up 6.5% on Wednesday . The stock traded as high as $0.65 and last traded at $0.65. 2,103 shares changed hands during mid-day trading, a decline of 87% from the average session volume of 16,610 shares. The stock had previously closed at $0.61.
Humacyte Stock Up 6.5 %
The company has a 50 day moving average of $0.69 and a two-hundred day moving average of $0.56.
Humacyte Company Profile
Humacyte, Inc engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection.
Further Reading
- Five stocks we like better than Humacyte
- Low PE Growth Stocks: Unlocking Investment Opportunities
- High-Yield Texas Instruments Could Hit New Highs Soon
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- How to Evaluate a Stock Before Buying
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Humacyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humacyte and related companies with MarketBeat.com's FREE daily email newsletter.
